MARKET CLARIFICATION ANNOUNCEMENT
ResApp Health Limited (ASX: RAP) advises that the UK-based medical device consultancy referenced in the announcement dated 29 May 2019 is Avanti Med Limited.
RAP Price at posting:
15.5¢ Sentiment: Buy Disclosure: Held